The largest database of trusted experimental protocols

Pqe 80l

Manufactured by Qiagen
Sourced in Germany

The PQE-80L is a laboratory equipment designed for DNA extraction and purification. It is a fully automated system that can process up to 80 samples simultaneously. The PQE-80L utilizes magnetic bead-based technology to efficiently extract and purify DNA from a variety of sample types, including blood, tissue, and cells. The system is capable of delivering high-quality DNA suitable for downstream applications such as PCR, sequencing, and genomic analysis.

Automatically generated - may contain errors

51 protocols using pqe 80l

1

Constructing Plasmid with Kanamycin Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 1

For construction of plasmid pQE-80L-Kana, Kanamycin resistance gene was cleaved from pET-24a(+) (Novagen) by BspHI (BioLab) to generate a 875-bp Kanamycin resistance gene (+3886 to +4760) fragment (SEQ ID NO: 1). The pQE-80L (Qiagen) vector was digested with BspHI to remove Ampicillin resistance gene (+3587 to +4699) fragment (SEQ ID NO:2) and then the Kanamycin resistance gene fragment was ligated into the pQE-80L vector to generate a 4513-bp plasmid (pQE-80L-Kana). (SEQ ID NO:3)

+ Open protocol
+ Expand
2

Cloning of the lacIq gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lacIq gene was extracted by McsI digestion from the expression vector pQE-80L (Quiagen). The 1610 bp fragment was cloned into the pBBR1MCS5 [31 (link)] previously digested with SmaI. The resulting plasmid pBBRlacIq was introduced into Sme Tn7pleD*Km strain using E. coli β2163 donor strain as described in [26 (link)].
+ Open protocol
+ Expand
3

Optimized Recombinant Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amino acid and DNA sequences chosen for experimental analysis were edited before cloning. Signal peptide was detected using the Phobius Tool [50 (link)] and removed. The coding sequences were optimized for E. coli expression by using the Integrated DNA Technologies (IDT) Codon Optimization Tool (www.idtdna.com). Native restriction sites were eliminated and SacI and SalI restriction sites were added in 5′ and 3′, respectively, to facilitate the cloning in vector pQE-80L (Quiagen).
+ Open protocol
+ Expand
4

Cloning and Purifying SdeC Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length sdeC genes were amplified by PCR and cloned into the bacterial expression vector pQE-80L (Qiagen) with BamHI and SacI restriction sites to generate a 6xHis-SdeC-StrepII fusion construct (Supplemental Table S1). Purification was as previously described22 (link). Purified aliquots were stored at −80°C in 10% glycerol to minimize or eliminate freeze thaw cycle degradation.
+ Open protocol
+ Expand
5

Recombinant Multi-Domain Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The (Azu-I27)4, (AzuC112A-I27)4, (AzuC26A-I27)4 and (Plasto-I27)4 polyproteins were subcloned using the BamHI, BglII and KpnI restriction sites59 . Synthetic gene for plastocyanin was produced by Life Technologies (Paisley, UK). The multidomain proteins were cloned into the pQE80L (Qiagen) expression vector, and transformed into the BLR(DE3) Escherichia coli expression strain. All mutations were introduced by using the QuikChange Site-Directed Mutagenesis kit (Agilent). The cells were grown in LB broth supplemented with 100 μg/mL ampicillin at 37°C. After reaching an OD600 of ~0.6 the cultures were induced with Isopropyl β-D-1-thiogalactopyranoside (1 mM) and incubated overnight at 20°C (constructs containing Azurin) or 16°C (Plastocyanin construct). For some constructs, CuSO4 (0.5 mM) was supplemented to the cultures right before induction to increase copper intake. After harvesting the cells, disruption using a French Press was performed. The polyproteins from the lysate were purified by metal affinity chromatography on Talon resin (Clontech) followed by gel-filtration using a Superdex 200 10/300 GL column (GE Biosciences). Protein concentration in the samples was estimated using the Bradford protein assay.
Details on the biochemistry characterization assays regarding circular dichroism, Ellman’s assays and ICP-OES measurements are detailed in the Supplementary Methods Section.
+ Open protocol
+ Expand
6

Multimeric Protein Constructs with Disulfide I27

Check if the same lab product or an alternative is used in the 5 most similar protocols
All multimeric constructs were created from multiple rounds of digestion and ligation using BamHI/BglII restriction sites as described previously(Wiita et al., 2006 (link)). The sequence of the disulfide containing I27 domain has been reported previously: two cysteine residues were introduced via QuickChange at positions G32 and A75, while the native cysteine residues at positions C47 and C63 were mutated to alanines (Ainavarapu et al., 2007 (link)). The N-terminal SpyCatcher and C-terminal Avi expression construct was designed in the pQE-80L (QIAGEN) plasmid for these experiments. The N-terminal HaloTag and C-terminal SpyTag was designed in the pFN18a plasmid (Promega).
+ Open protocol
+ Expand
7

Recombinant HSP Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length HSP1 (CmsHSP1) and HSP22F (CreHSP22F) genes were amplified and cloned in pQE-80 L (Qiagen, Venlo, The Netherlands). The vectors were transformed into Escherichia coli BL21 and selected on Luria–Bertani (LB) agar medium containing 50 µg/ml Carbenicillin (Nacalai Tesque, Kyoto, Japan). The cultures were grown in LB medium at 37 °C for several hours and isopropyl β-D-1-thiogalactopyranoside (IPTG) was added at OD 600 0.7–1 to a final concentration of 1 mM. Proteins were purified using Ni-NTA agarose (Qiagen), following the manufacturer’s instructions. The isolated CmsHSP1 and CreHSP22F fusion proteins were injected into mice.
+ Open protocol
+ Expand
8

Generating Bacterial Strain Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
All strains, plasmids and primers used in this study are listed in Tables S5, S6 and S7, respectively. All plasmids used for in vivo experiments are derivatives of pJN105 (Newman & Fuqua, 1999 (link)). Amino acid substitutions in the DPBB domain of RlpA were generated using a multistep PCR procedure involving megapriming (Kwok et al., 1994 (link)). Plasmids for overproducing hexahistidine (His6-) tagged RlpA variants are derivatives of pQE-80L (Qiagen). All strains used for in vivo experiments are derivatives of P. aeruginosa strain UCBPP- PA14. All deletion constructs were generated using plasmid pEXG2 as previously described (Rietsch et al., 2005 (link)). pEXG2 derivatives were transferred from derivatives of E. coli strain SM10 to wild type PA14 by conjugation as described (Schweizer, 1992 (link)) except that Irg was used to counter select against the E. coli donor strain because a ΔrlpA mutant is not viable on the (low osmolarity) minimal-citrate media often used to counter select E. coli after such matings. Resolution of the co-integrant was selected for on LB0N plates containing 5% sucrose (~150 mM, which allows for growth of the ΔrlpA mutant in the absence of NaCl).
+ Open protocol
+ Expand
9

Protein Expression in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Escherichia coli SURE 2 Supercompetent Cells [e14(McrA-) Δ(mcrCB-hsdSMR-mrr) 171 endA1 gyrA96 thi-1 supE44 relA1 lac recB recJ sbsC umuC::Tn5 (Kanr) uvrC [F’ proAB lacIqZΔM15 Tn10 (Tetr)]] (Agilent Technologies, Santa Clara, CA, USA) was used as a host strain in order to verify the gene sequences. For protein expression, recombinant pQE-80L (Qiagen, Hilden, Deutschland) vectors were transformed into E. coli BL21-CodonPlus(DE3)-RIPL [E. coli B FompT hsdS(rB mB) dcm+ Tetr gal λ(DE3) endA Hte [argU proL Camr] [argU ileY leuW Strep/Specr]] (Agilent Technologies). Bacteria were cultivated at 37 °C and 18 °C on Luria-Bertani solid medium (0.1% peptone, 0.05% yeast extract, 0.1% sodium chloride, 0.1% agar) or Luria-Bertani liquid medium (0.1% peptone, 0.05% yeast extract, 0.1% sodium chloride).
+ Open protocol
+ Expand
10

Codon-Optimized Recombinant Human TRAIL and DR5 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human TRAIL cDNA fragment (coding amino acids 94–281) was codon optimized, synthesized by IDT (Integrated DNA Technologies, Inc. Coralville, Iowa) and inserted into a bacterial expression vector, pQE80L (Qiagen) to generate a His-tagged human recombinant TRAIL, which was purified per a protocol published previously (21 (link)). The human DR5 cDNA fragment (coding amino acids from 1 to 334) was codon optimized and synthesized by IDT, fused with EGFP at the C-terminus, and cloned into the pBabe-puro retroviral vector. The ORF of galectin-3 was codon optimized and synthesized by IDT and cloned into thepLVEF-1a lentivirus expression vector (kindly provided by Dr. Guihua Sun, Diabetes & Metabolism Research Institute at City of Hope) fused with mCherry at the N-terminus. For retrovirus production, the pBabe/DR5-EGFP plasmid was transfected into Phoenix cells for packaging. Virus containing supernatant was harvested 48–72 h post-transfection for target cell infection in the presence of polybrene at 10 μg/ml. The lentivirus vector pLVEF-1a-mCherry-galection-3 was co-transfected into 293T cells with packaging plasmids for lentivirus production. Virus containing supernatant was harvested 48–72 h post-transfection and purified for target cell infection in the presence of polybrene at 10 μg/ml.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!